Sumitomo Mitsui DS Asset Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.35M | Buy |
12,071
+121
| +1% | +$67.9K | 0.04% | 302 |
|
|
2026
Q1 | $6.71M | Buy |
11,950
+172
| +1% | +$110K | 0.05% | 266 |
|
|
2025
Q4 | $7.97M | Sell |
11,778
-15,667
| -57% | -$10.7M | 0.06% | 230 |
|
|
2025
Q3 | $17.5M | Buy |
27,445
+6,832
| +33% | +$4.15M | 0.14% | 136 |
|
|
2025
Q2 | $11.1M | Sell |
20,613
-92
| -0.4% | -$44K | 0.1% | 173 |
|
|
2025
Q1 | $8.7M | Buy |
20,705
+605
| +3% | +$263K | 0.09% | 183 |
|
|
2024
Q4 | $8.31M | Sell |
20,100
-4,108
| -17% | -$1.8M | 0.08% | 188 |
|
|
2024
Q3 | $12.2M | Buy |
24,208
+1,394
| +6% | +$677K | 0.13% | 142 |
|
|
2024
Q2 | $11.1M | Buy |
22,814
+125
| +0.6% | +$62.8K | 0.13% | 140 |
|
|
2024
Q1 | $12.3M | Buy |
22,689
+288
| +1% | +$157K | 0.15% | 128 |
|
|
2023
Q4 | $12.4M | Sell |
22,401
-1,736
| -7% | -$815K | 0.16% | 136 |
|
|
2023
Q3 | $10.6M | Sell |
24,137
-1,617
| -6% | -$806K | 0.16% | 116 |
|
|
2023
Q2 | $12.9M | Buy |
25,754
+5,114
| +25% | +$2.45M | 0.2% | 97 |
|
|
2023
Q1 | $10.3M | Buy |
20,640
+136
| +0.7% | +$65.1K | 0.19% | 98 |
|
|
2022
Q4 | $8.36M | Buy |
20,504
+471
| +2% | +$183K | 0.17% | 115 |
|
|
2022
Q3 | $6.53M | Buy |
20,033
+335
| +2% | +$123K | 0.15% | 126 |
|
|
2022
Q2 | $6.91M | Sell |
19,698
-3,159
| -14% | -$1.29M | 0.17% | 114 |
|
|
2022
Q1 | $12.5M | Buy |
22,857
+2,560
| +13% | +$1.35M | 0.27% | 80 |
|
|
2021
Q4 | $13.4M | Buy |
20,297
+1,272
| +7% | +$799K | 0.28% | 76 |
|
|
2021
Q3 | $11.8M | Sell |
19,025
-3,608
| -16% | -$2.42M | 0.28% | 79 |
|
|
2021
Q2 | $14.3M | Buy |
22,633
+171
| +0.8% | +$94.4K | 0.34% | 64 |
|
|
2021
Q1 | $11M | Buy |
22,462
+7,184
| +47% | +$3.6M | 0.29% | 74 |
|
|
2020
Q4 | $7.64M | Buy |
15,278
+5,554
| +57% | +$2.49M | 0.22% | 98 |
|
|
2020
Q3 | $3.82M | Buy |
9,724
+1,053
| +12% | +$389K | 0.12% | 153 |
|
|
2020
Q2 | $2.86M | Sell |
8,671
-519
| -6% | -$150K | 0.1% | 178 |
|
|
2020
Q1 | $2.23M | Buy |
9,190
+318
| +4% | +$83K | 0.09% | 192 |
|
|
2019
Q4 | $2.32M | Sell |
8,872
-250
| -3% | -$65.9K | 0.08% | 238 |
|
|
2019
Q3 | $2.48M | Sell |
9,122
-686
| -7% | -$191K | 0.09% | 224 |
|
|
2019
Q2 | $2.7M | Buy |
9,808
+3,952
| +67% | +$974K | 0.11% | 184 |
|
|
2019
Q1 | $1.31M | Buy |
5,856
+83
| +1% | +$17.1K | 0.02% | 442 |
|
|
2018
Q4 | $1.07M | Sell |
5,773
-195
| -3% | -$40K | 0.02% | 439 |
|
|
2018
Q3 | $1.49M | Sell |
5,968
-77
| -1% | -$18.7K | 0.02% | 418 |
|
|
2018
Q2 | $1.32M | Buy |
6,045
+28
| +0.5% | +$5.77K | 0.02% | 450 |
|
|
2018
Q1 | $1.15M | Sell |
6,017
-125
| -2% | -$23.1K | 0.02% | 470 |
|
|
2017
Q4 | $960K | Sell |
6,142
-850
| -12% | -$134K | 0.01% | 532 |
|
|
2017
Q3 | $1.09M | Buy |
6,992
+28
| +0.4% | +$4.43K | 0.02% | 460 |
|
|
2017
Q2 | $1.12M | Sell |
6,964
-509
| -7% | -$82.7K | 0.02% | 448 |
|
|
2017
Q1 | $1.16M | Buy |
7,473
+1,619
| +28% | +$223K | 0.02% | 444 |
|
|
2016
Q4 | $686K | Sell |
5,854
-223
| -4% | -$25.4K | 0.01% | 552 |
|
|
2016
Q3 | $685K | Buy |
6,077
+245
| +4% | +$25.8K | 0.01% | 544 |
|
|
2016
Q2 | $541K | Buy |
+5,832
| New | +$501K | 0.02% | 573 |
|
Other funds holding IDXX
Sumitomo Mitsui DS Asset Management's IDXX Position: Q2 2026 in Review
Sumitomo Mitsui DS Asset Management increased its Idexx Laboratories (IDXX) stake by 1% in Q2 2026, buying an estimated $67.9K and bringing the position to 12,071 shares worth $6.35M. The position accounts for 0.04% of the portfolio, ranked #302.
Sumitomo Mitsui DS Asset Management first reported a position in IDXX in Q2 2016 and has held it in 41 quarters since. The position peaked at $17.5M in Q3 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Sumitomo Mitsui DS Asset Management held 12,071 shares of Idexx Laboratories worth $6.35M as of Q2 2026.
- Sumitomo Mitsui DS Asset Management bought 121 Idexx Laboratories shares in Q2 2026, an estimated $67.9K.
- Idexx Laboratories made up 0.04% of Sumitomo Mitsui DS Asset Management's portfolio in Q2 2026, its #302 holding.
- Sumitomo Mitsui DS Asset Management first reported a position in Idexx Laboratories in Q2 2016 and has held it in 41 quarters since.
- Sumitomo Mitsui DS Asset Management's Idexx Laboratories position peaked at $17.5M in Q3 2025.
- 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Sumitomo Mitsui DS Asset Management's 13F filing for Q2 2026, filed 22 Jul 2026.